Abbreviations
- DM :
-
dextromethorphan
- MCD :
-
molybdenum cofactor deficiency
- NMDA :
-
N-methyl-D-aspartate
References
Ferkany JW, Borosky SA, Clissold DB, Pontecorvo J (1988) Dextromethorphan inhibits NMDA-induced convulsion. Eur J Pharmacology 151: 151–154
Johnson JL, Wadman SK (1988) Molydenum cofactor deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1463–1475
Olney JW, Misra CH, Gubareff T de (1975) Cysteine-S-sulfate: brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol 34: 167–177
Schmitt B, Steinmann B, Gitzelmann R, Thun-Hohenstein L, Mascher H, Dumermuth G (1993) Nonketotic hyperglycinemia: clinical and electrophysiologic effects of dextromethorphan, an antagonist of the NMDA receptor. Neurology 43: 421–424
Schuierer G, Kurlemann G, Bick U, Stephani U (1995) Molybdenum cofactor deficiency: CT and MR findings. Neuropediatrics 26: 51–54
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurlemann, G., Debus, O. & Schuierer, G. Dextrometorphan in molybdenum cofactor deficiency. Eur J Pediatr 155, 422–423 (1996). https://doi.org/10.1007/BF01955280
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01955280